SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Holdings Decreased by Raymond James & Associates

Raymond James & Associates cut its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 50.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,183 shares of the company’s stock after selling 6,393 shares during the quarter. Raymond James & Associates owned 0.12% of SPDR S&P Pharmaceuticals ETF worth $257,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. AE Wealth Management LLC raised its position in shares of SPDR S&P Pharmaceuticals ETF by 2.4% during the 3rd quarter. AE Wealth Management LLC now owns 12,258 shares of the company’s stock worth $487,000 after purchasing an additional 292 shares during the period. Janney Montgomery Scott LLC boosted its stake in SPDR S&P Pharmaceuticals ETF by 9.4% during the 3rd quarter. Janney Montgomery Scott LLC now owns 5,835 shares of the company’s stock valued at $232,000 after purchasing an additional 500 shares during the period. First Citizens Bank & Trust Co. grew its position in SPDR S&P Pharmaceuticals ETF by 1.3% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 58,439 shares of the company’s stock worth $2,323,000 after purchasing an additional 748 shares during the last quarter. NBC Securities Inc. acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the third quarter worth approximately $93,000. Finally, Ieq Capital LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at approximately $550,000.

SPDR S&P Pharmaceuticals ETF Trading Up 1.2 %

SPDR S&P Pharmaceuticals ETF stock opened at $39.98 on Tuesday. SPDR S&P Pharmaceuticals ETF has a 52 week low of $34.67 and a 52 week high of $45.62. The stock has a market cap of $195.90 million, a price-to-earnings ratio of 14.45 and a beta of 0.87. The company’s 50-day moving average price is $42.28 and its two-hundred day moving average price is $40.61.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.